Reference Laboratory Genetics

referencelaboratory.es

Since its foundation in 1975, Reference Laboratory has established itself as one of the leading European laboratories in special analysis. We are the largest laboratory in Europe (15.000m2) and we currently collaborate with more than 400 hospitals and over 1,000 laboratories around the world. Reference Laboratory Genetics is our Genetics and Molecular Diagnostics Division.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Medical

JNANA THERAPEUTICS ANNOUNCES POSITIVE CLINICAL PROOF OF CONCEPT ACHIEVED WITH JNT-517, A POTENTIAL FIRST-IN-CLASS ORAL TREATMENT FOR PKU

Jnana Therapeutics, Inc. | February 02, 2024

news image

Jnana Therapeutics, a clinical-stage biotechnology company leveraging its next-generation chemoproteomics platform to discover medicines for challenging-to-drug targets, today announced positive, statistically significant interim results from its ongoing clinical study of JNT-517 in individuals with phenylketonuria (PKU). JNT-517, a small molecule inhibitor of the phenylalanine (Phe) transporter SLC6A19, is being evaluated as a potential first-in-class oral treatment for PKU across all age...

Read More

Industrial Impact

ADM FURTHER EXPANDS MICROBIAL SCIENCE AND TECHNOLOGY INNOVATION CAPABILITIES WITH INVESTMENT IN PRECISION FERMENTATION LEADER ACIES BIO

ADM | October 22, 2021

news image

ADM a global leader in nutrition and agricultural origination and processing, annoThis investment will help ADM more quickly advance projects in the field of precision microbial fermentation by leveraging Acies Bio’s extensive microbial capabilities and contract manufacturing services. “Microbial technology is unlocking disruptive opportunities in sustainable agriculture, sustainable materials and fuels, and alternative proteins, We’re prope...

Read More

Industry Outlook

TEMPUS ANNOUNCES COMPANION DIAGNOSTIC COLLABORATION WITH TSCAN THERAPEUTICS

Businesswire | July 07, 2023

news image

Tempus, a leader in artificial intelligence and precision medicine, announced a new collaboration to develop a companion diagnostic (CDx) test with TScan Therapeutics, a clinical-stage biopharmaceutical company focused on the development of T cell receptor (TCR)-engineered T cell therapies (TCR-T) for the treatment of cancer patients. The collaboration supports TScan’s screening protocol for its Phase 1 solid tumor clinical trial which is designed to enable customized mixtures of TCR...

Read More

Medical

TEXAS CHILDREN'S PAVILION FOR WOMEN ACQUIRES AUSTIN PERINATAL ASSOCIATES EXPANDING HOSPITAL'S MATERNAL-FETAL MEDICINE FOOTPRINT TO CENTRAL TEX

Texas Children's Hospital | May 09, 2022

news image

Texas Children's Physician Group announced today that it has completed the acquisition of Austin Perinatal Associates, a well-known private maternal-fetal medicine practice based in Austin. Located at 6500 North Mopac Expressway, the facility is the ninth community maternal-fetal medicine clinic operated by the Texas Children's Pavilion for Women and the first to offer women's services in Central Texas – bringing the hospital's well-known, top tier women'...

Read More
news image

Medical

JNANA THERAPEUTICS ANNOUNCES POSITIVE CLINICAL PROOF OF CONCEPT ACHIEVED WITH JNT-517, A POTENTIAL FIRST-IN-CLASS ORAL TREATMENT FOR PKU

Jnana Therapeutics, Inc. | February 02, 2024

Jnana Therapeutics, a clinical-stage biotechnology company leveraging its next-generation chemoproteomics platform to discover medicines for challenging-to-drug targets, today announced positive, statistically significant interim results from its ongoing clinical study of JNT-517 in individuals with phenylketonuria (PKU). JNT-517, a small molecule inhibitor of the phenylalanine (Phe) transporter SLC6A19, is being evaluated as a potential first-in-class oral treatment for PKU across all age...

Read More
news image

Industrial Impact

ADM FURTHER EXPANDS MICROBIAL SCIENCE AND TECHNOLOGY INNOVATION CAPABILITIES WITH INVESTMENT IN PRECISION FERMENTATION LEADER ACIES BIO

ADM | October 22, 2021

ADM a global leader in nutrition and agricultural origination and processing, annoThis investment will help ADM more quickly advance projects in the field of precision microbial fermentation by leveraging Acies Bio’s extensive microbial capabilities and contract manufacturing services. “Microbial technology is unlocking disruptive opportunities in sustainable agriculture, sustainable materials and fuels, and alternative proteins, We’re prope...

Read More
news image

Industry Outlook

TEMPUS ANNOUNCES COMPANION DIAGNOSTIC COLLABORATION WITH TSCAN THERAPEUTICS

Businesswire | July 07, 2023

Tempus, a leader in artificial intelligence and precision medicine, announced a new collaboration to develop a companion diagnostic (CDx) test with TScan Therapeutics, a clinical-stage biopharmaceutical company focused on the development of T cell receptor (TCR)-engineered T cell therapies (TCR-T) for the treatment of cancer patients. The collaboration supports TScan’s screening protocol for its Phase 1 solid tumor clinical trial which is designed to enable customized mixtures of TCR...

Read More
news image

Medical

TEXAS CHILDREN'S PAVILION FOR WOMEN ACQUIRES AUSTIN PERINATAL ASSOCIATES EXPANDING HOSPITAL'S MATERNAL-FETAL MEDICINE FOOTPRINT TO CENTRAL TEX

Texas Children's Hospital | May 09, 2022

Texas Children's Physician Group announced today that it has completed the acquisition of Austin Perinatal Associates, a well-known private maternal-fetal medicine practice based in Austin. Located at 6500 North Mopac Expressway, the facility is the ninth community maternal-fetal medicine clinic operated by the Texas Children's Pavilion for Women and the first to offer women's services in Central Texas – bringing the hospital's well-known, top tier women'...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us